Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and Danish firm Novo Nordisk.

The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...

Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang Vohra has ...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...

VinFast Auto India has entered into agreements with 13 dealership groups to open 32 showrooms across 27 cities, aiming to scale up to 35 outlets by the end of 2025. This expansion aligns with the ...